Intuitive Surgical, Inc. (NEO:ISRG)
30.20
-0.12 (-0.40%)
At close: Nov 27, 2025
Intuitive Surgical Revenue
Intuitive Surgical had revenue of $2.51B USD in the quarter ending September 30, 2025, with 22.91% growth. This brings the company's revenue in the last twelve months to $9.61B, up 22.18% year-over-year. In the year 2024, Intuitive Surgical had annual revenue of $8.35B with 17.24% growth.
Revenue (ttm)
$9.61B
Revenue Growth
+22.18%
P/S Ratio
21.37
Revenue / Employee
$614.66K
Employees
15,638
Market Cap
286.06B CAD
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.35B | 1.23B | 17.24% |
| Dec 31, 2023 | 7.12B | 901.90M | 14.49% |
| Dec 31, 2022 | 6.22B | 512.10M | 8.97% |
| Dec 31, 2021 | 5.71B | 1.35B | 31.01% |
| Dec 31, 2020 | 4.36B | -120.10M | -2.68% |
| Dec 31, 2019 | 4.48B | 754.30M | 20.25% |
| Dec 31, 2018 | 3.72B | 586.00M | 18.67% |
| Dec 31, 2017 | 3.14B | 431.70M | 15.95% |
| Dec 31, 2016 | 2.71B | 322.10M | 13.51% |
| Dec 31, 2015 | 2.38B | 252.70M | 11.85% |
| Dec 31, 2014 | 2.13B | -133.40M | -5.89% |
| Dec 31, 2013 | 2.27B | 86.30M | 3.96% |
| Dec 31, 2012 | 2.18B | 421.50M | 23.99% |
| Dec 31, 2011 | 1.76B | 344.30M | 24.37% |
| Dec 31, 2010 | 1.41B | 360.80M | 34.29% |
| Dec 31, 2009 | 1.05B | 177.30M | 20.27% |
| Dec 31, 2008 | 874.90M | 274.07M | 45.62% |
| Dec 31, 2007 | 600.83M | 228.15M | 61.22% |
| Dec 31, 2006 | 372.68M | 145.34M | 63.93% |
| Dec 31, 2005 | 227.34M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Curaleaf Holdings | 1.78B |
| dentalcorp Holdings | 1.66B |
| Trulieve Cannabis | 1.66B |
| Green Thumb Industries | 1.61B |
| Extendicare | 1.59B |
| WELL Health Technologies | 1.25B |
| Sienna Senior Living | 967.05M |
| Knight Therapeutics | 413.85M |